. Descriptions, equations, and variables are derived from this reference and are included here with discussion of portions relevant for this work. The model is comprised of five ODEs tracking the levels of nanosensor (substrate tethered onto nanoparticle) and reporters (fragments used for detection) in three compartments (Blood, Tumor, Bladder). The model is deterministic and has several simplifying assumption, such as a well-mixed assumption 1 . After injection, in blood, nanosensors can be depleted by blood proteases (either off-target or secreted proteases from the tumor), diffuse into the tumor, and taken up by the host phagocytic/clearance system. This is described by the following equation: 
where the first two terms are derived from nanoparticle scaffold half-life and permeability into the tumor and the last two from Michaelis-Menten analysis. In the original derivation, 45671 #$ =1.4e-4 min -1 , -04 JJ$K = 0.5 min -1 , and -04 L.77M =6.6e-2 min -1 . These parameters were multiplied by scalar factors of 1.2, 4.0, and 0.03, respectively, to account for the improvements observed in optimization experiments described in Fig.  2 . Here, we assume that the change in cleavage rates at the highest substrate concentration tested in vitro (6 µM) apply for simplicity, as well generalize the decrease in thrombin cleavage to background blood cleavage. In the tumor bed, nanosensor concentration increases as they diffuse into the tumor and get depleted as they are cleaved by proteases. Q * Q 8NO'P (3) In the blood, reporters can be generated either by proteolytic cleavage in the tumor or by reporters entering from the tumor bed and depleted by clearance, urinary filtration, or nonspecific absorption in the kidney. All starting variables were either fit to experimental data in a mouse model of colorectal cancer or from biochemical assays of proteolysis of our selected substrate 1 . Tumor enzyme concentration was set 700 nM for a 10-mm tumor and 7 nM for a 5-mm tumor. This estimation was arrived at by measuring MMP9 secretion rates of four human colorectal cancer cell lines 1 . The concentration of MMP9 in blood is modeled as one-tenth of tumor concentration based on previous estimation of protein secretion into blood from tumors 2 . For control urine signal, the tumor compartment and all associated variables are omitted. Detection signal is defined as tumor - control urine signal. The core skeleton code has been deposited on GitHub (https://github.com/jaidud3/Canceractivity-based-nanosensor-mathematical-framework). The code was run in MATLAB R2013b. 
